Industry News
Pharmaceutical Industry News
FDA shares advice on bioequivalence studies for different dosage forms
FDA shares advice on bioequivalence studies for different dosage forms ntaylor Tue, 08/24/2021 - 06:34
Xeris, a rival to Lilly and Novo, gets FDA nod for glucagon kit
Xeris, a rival to Lilly and Novo, gets FDA nod for glucagon kit ntaylor Tue, 08/24/2021 - 06:31
Magnetic pills deliver insulin to refill implanted reservoir
Magnetic pills deliver insulin to refill implanted reservoir ntaylor Tue, 08/24/2021 - 06:27
They Still Live in the Shadow of Theranos’s Elizabeth Holmes
Female entrepreneurs said they were constantly compared to Ms. Holmes, the disgraced founder of Theranos, who faces trial soon.
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users bbulik Mon, 08/23/2021 - 20:59
F.D.A. Fully Approves Pfizer Vaccine
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
FDA hands Cara, Vifor a consolation prize with Korsuva nod in pruritis for chronic kidney disease patients
FDA hands Cara, Vifor a consolation prize with Korsuva nod in pruritis for chronic kidney disease patients kdunleavy Mon, 08/23/2021 - 18:47
FDA hands Cara, Vifor a consolation prize with Korsuva nod in pruritus for chronic kidney disease patients
FDA hands Cara, Vifor a consolation prize with Korsuva nod in pruritus for chronic kidney disease patients kdunleavy Mon, 08/23/2021 - 18:47
Lonza invests yet again, this time with a fill-finish line at new manufacturing site in Guangzhou, China
Lonza invests yet again, this time with a fill-finish line at new manufacturing site in Guangzhou, China kdunleavy Mon, 08/23/2021 - 13:32
Bristol Myers Squibb nabs priority review tag for $3.15B arthritis drug Orencia to prevent transplant rejection
Bristol Myers Squibb nabs priority review tag for $3.15B arthritis drug Orencia to prevent transplant rejection fkansteiner Mon, 08/23/2021 - 11:23
ESC: Amarin touts Vascepa’s ability to reduce repeat heart problems as it fights generic with ‘skinny label’ claim
ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim aliu Mon, 08/23/2021 - 11:17
Pfizer, BioNTech score FDA’s first full COVID-19 vaccine nod, quickly triggering stricter mandates
Pfizer, BioNTech score FDA's first full COVID-19 vaccine nod, quickly triggering stricter mandates nhigginsdunn Mon, 08/23/2021 - 10:59
After vandalism during unrest in South Africa, India-based Cipla reopens Durban manufacturing site
After vandalism during unrest in South Africa, India-based Cipla reopens Durban manufacturing site kdunleavy Mon, 08/23/2021 - 09:59
FDA puts Jubilant Generics plant through the wringer for cleaninless, quality flubs
FDA puts Jubilant Generics plant through the wringer for cleaninless, quality flubs fkansteiner Mon, 08/23/2021 - 09:34
Coffee talk: Sun brings Ilumya patient stories to light with informal diner meetups
Coffee talk: Sun brings Ilumya patient stories to light with informal diner meetups bbulik Mon, 08/23/2021 - 09:15
La vida con TOC en una pandemia
La pandemia empeoró las cosas para muchas personas con trastorno obsesivo compulsivo. Pero también tuvo su lado positivo.
Ivermectin Should Not Be Used to Treat Covid, F.D.A. Says
“You are not a horse,” the Food and Drug Administration said. “Stop it.”
F.D.A. Aims for Full Approval of Pfizer Covid Vaccine on Monday
Federal regulators are winding down the process of licensing Pfizer’s two-dose coronavirus vaccine, setting up an approval possibly by Monday and potentially kicking off a wave of new mandates.
¿La vacuna Johnson & Johnson requerirá refuerzo?
Tenemos una guía con las recomendaciones y opiniones de los expertos en salud para despejar tus dudas.
ESC 2021: Lexicon aims to make its heart failure case with sotagliflozin, a dual SGLT1 and SGLT2 inhibitor
ESC 2021: Lexicon aims to make its heart failure case with sotagliflozin, a dual SGLT1 and SGLT2 inhibitor esagonowsky Fri, 08/20/2021 - 14:18